Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...
Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...
The FDA’s move to lift the hold on Zentalis Pharmaceuticals’ sole clinical-stage drug may have been good news for the biotech ...
The completion of chromosome synXVI allows scientists to explore new possibilities in metabolic engineering and strain ...
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara ...
Circio partners with 4basebio to develop synthetic “circVec” DNA vectors for in vivo gene therapy delivery. The collaboration ...
The synthetic chromosome includes features that enable researchers to generate genetic diversity on demand, accelerating the development of yeasts with enhanced capabilities for biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback